Lecture 18: Metabolic syndrome Flashcards

1
Q

Define insulin resistance:

A

Given insulin conc. -> Subnormal glucose response

i.e high insulin with normal/high glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Where can insulin resistance occur?

A

pre-receptor, receptor or post receptor (most common)

Precedes diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is insulin resistance associated with?

A
  1. Obesity
  2. Type 2 diabetes
  3. Metabolic syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Insulin resistance may be recognised due to the metabolic syndrome cluster, describe this:

A

Possibly fetal programming or genetic predisposition along with:

  • Excess energy intake
  • Decreased physical activity leads to:

TRUNCAL OBESITY
= INSULIN RESISTANCE

leads to:

  • Glucose intolerance (T2D)
  • Hypertension
  • Fatty liver
  • Dyslipidemia
  • Endothelial dysfunction (inflam markers (procoagulant)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What must a pt have to be said to have the metabolic syndrome cluster?

A

Central obesity (waist measures)

+2 of:

  • Hypertension
  • abnormal glucose
  • high triglycerides
  • Low HDL cholesterol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why does fat deposition matter?

A

Can be fat on the outside of fat on the inside. Inside fat matters most.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What can tell us if a patient has insulin resistance?

A
  1. Metabolic syndrome cluster
  2. Acanthosis nigricans (pits, neck darken)
  3. PCOS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What causes insulin resistance?

A
  • Increased visceral fat, stored TG and large adipocytes
  • Large adipocytes are resistant to insulins ability to suppress lipolysis.
  • Inc. lipolysis = increased non-esterfied FA (NEFA) and glycerol
  • NEFA and Glycerol, plus proinflam cytokines from visceral adipose tissue (i.e TNFa and IL6) aggrevate insulin resistance in muscle and liver.
  • (Might also cause lipotoxicity to beta cell)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Are adiponectin and/or resistin implicated in insulin resistance?

A
  • Adiponectin deficiency may cause development of insulin resistance
  • Resistin is secreted by adipocytes of obese mice and decreases adipocyte glucose uptake….
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What happens to the insulin signalling in insulin resistance?

A

In insulin resistant states, insulin signalling is blocked by inhibition of p/ph of insulin receptor substrate proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

insert slide 31

A

plz

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Whats the impact of insulin resistance on glucose?

A
  • Hepatic glucose output is not suppressed
  • IMGU in muscle is reduced
  • Thus only hyperinsulinaemia can maintain normal glucose levels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Whats the impact of insulin resistance on fat?

A

Metabolic - rise in FFA, TGs (dyslipidaemia)

Hormones - Adipocytokines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the consequences of insulin resistance?

A

Glucose rises -> Glucose toxicity in beta cells
FFA rise -> Lipotoxicity in beta cell, liver and muscle

Failing beta cells: Poor acute / first phase insulin release = post prandial hyperglyceamia
= Alpha cell dysregulation and hyperglucogonaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Whats the critical step in going from insulin resistance to type two diabetes?

A

Beta cell dysfunction critical step in pathogenesis of T2D

Dec. beta cell mass = genetic or intrauterine

Dec. beta cell function = Less pulses, lipo and glucotoxicity, incretin dysfunction

BETA CELL DYSFUNCTION IS PROGRESSIVE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Beta cell destruction is what sort of process?

A

Progressive

17
Q

insert slide 41

A

thanks

18
Q

What is DM?

A

Metabolic disorder characterised by the presence of hyperglyceamia due to defective insulin secretion, insulin action or both.

or

disorder of premature widespread atherosclerosis with hyperglyceamia as an assocaited feature (waaat)

19
Q

What range of fasting blood glucose is referred to as impaired glucose tolerance?

A

5.5-7mmol/L

20
Q

What is seen with an OGTT? insert slide 46 when blood glucose is measured

A
  • An obsese normal person will handle glucose the same as a lean normal
  • A lean or obese type 2 diabetic will not handle the oral glucose tolerance test
21
Q

What is seen on a OGTT when blood insulin is measured? (slide 50)

A
  • A lean T2D will have very little insulin produced.
  • An obese normal will have a more pronounced insulin release than lean normal.
  • An obese type 2 diabetic will not have the acute phase insulin release and will gradually achieve a somewhat decent insulin level
22
Q

What is the HBA1C diagnostic criteria for diabetes?

A

Normal <40mmol/mol
Abnormal 41-49
Diabetes 50+

And/or fasting glucose >7mmol/L

23
Q

Is treatment of diabetes dependent on type?

A

No, depends on blood glucose levels.

24
Q

What are the microvascular and macrovascular complications of diabetes?

A

Microvascular

  • Retinopathy
  • Peripheral neuropathy (mono and autonomic)
  • Nephropathy

Macrovascular

  • IHD
  • PVD
  • CVA
25
Q

What are the risk factors for atherosclerosis cluster?

A

Diabetes + Hypertension + Dyslipidemia + Smoking

= Cerebrovascular disease (CVD), IHD, peripheral vascular disease (CVD)

NB better glyceamic control alone only has modest effects

Important to address all CVD risk factors

26
Q

What does the typical patient with type 2 diabetes look like?

A
  • Obese
  • Metabolic syndrome features
  • Family history of type 2 diabetes
  • Older
  • Doesnt need insulin for 5-10 years post diagnosis
27
Q

How is diabetes managed?

A
  • Diet + exercise

Meds of glucose control

  • Insulin
  • Metformin
  • Sulphonyurea
  • Insulin incretin therapy
  • SGLT2 inhibitors
  • Attend to BP, lipids, smoking etc